Condition: Diabetic Retinopathy · NPDR - Non Proliferative Diabetic Retinopathy · Sponsor: Vantage Biosciences Ltd
The goal of this clinical trial is to evaluate the efficacy, safety, pharmacokinetics (PK) and pharmacodynamics (PD) of VX-01 as stand-alone treatment for Diabetic Retinopathy of Non-Proliferative Type (NPDR). The primary objective of the study is to evaluate the efficacy of daily oral doses of VX-01 versus placebo following 52 weeks of treatment.
This description comes directly from the study's public registry record.
Steffy George · +44 7450953382 · steffy.george@vantage-biosciences.com
Always discuss trial participation with your own doctor first.
| Retina-Vitreous Associates Medical Group | Beverly Hills, California, United States | Not Yet Recruiting |
| Stanford Byers Eye Institute | Palo Alto, California, United States | Not Yet Recruiting |
| California Retina Consultants- Santa Barbara | Santa Barbara, California, United States | Not Yet Recruiting |
| Florida Retina Institute - Jacksonville Southside | Jacksonville, Florida, United States | Not Yet Recruiting |
| Retina Associates | Elmhurst, Illinois, United States | Not Yet Recruiting |
| Cumberland Valley Retina Consultants | Hagerstown, Maryland, United States | Not Yet Recruiting |
| Erie Retina Research | Erie, Pennsylvania, United States | Not Yet Recruiting |
| Piedmont Eye Center | Lynchburg, Virginia, United States | Not Yet Recruiting |
| Eye Clinic Albury Wodonga | Albury, New South Wales, Australia | Recruiting |
| Retina And Eye Consultants Hurstville | Hurstville, New South Wales, Australia | Recruiting |
| Marsden Eye Specialists | Parramatta, New South Wales, Australia | Recruiting |
| Sydney Eye Hospital | Sydney, New South Wales, Australia | Recruiting |
+ 14 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06770933